For Libraries For Publication Open Access Downloads About Us Contact Us
Paper Titles
Fe3O4@TiO2 Nanocomposites for Magnetic Targeting Sonodynamic Therapy of Cancer
p.129
Extraction of Porphyran from Porphyra yezoensis for Gel Formulation Preparation
p.133
A Novel Chitosan Microbubble as Ultrasound-Triggered Drug Carrier for Antitumor In Vitro
p.139
Biological Synthesis of D-Tagatose Using L-Arabinose Isomerase
p.145
Microbial Bioconversion Process of Glucose for the Production of Xylitol
p.149
Synthesis and Characterization of Ultrafine CeO2 Nanoparticles with Photocatalytic Antibacterial Property
p.153
Pharmacology Research Progress of Phenolic Alkaloids from Menisphermum dauricum
p.157
Pharmacology Research Progress of Paeonol
p.163
Cardiovascular Pharmacology Research Progress of Hawthorn Leaves Extract
p.167

Pharmacology Research Progress of Phenolic Alkaloids from Menisphermum dauricum

Article Preview

Abstract:

Phenolic alkaloids from Menisphermum dauricum (PAMD) was a compound of multiple fat soluble alkaloid extracted from Rhizoma Menispermi. PAMD had wide pharmacological effects including of anti-arrhythmia, anti-MI, anti-thrombosis, anti-dementia, anti-cancer, anti-inflammatory, inhibiting respiratory depression, influencing on heart electrophysiology, ptotecting heart and nerve after cerebral ischemia, suppressing pain, lowering blood pressure, improving learning disorder and so on.

You might also be interested in these eBooks
Recent Highlights in Advanced Functional Materials and Biomedical Research View Preview

Info:

Periodical:

Key Engineering Materials (Volume 636)

Pages:

157-162

DOI:

https://doi.org/10.4028/www.scientific.net/KEM.636.157

Citation:

Cite this paper

Online since:

December 2014

Authors:

Qi Guo*, Qi Jiang, Zhi Guo Wang

Keywords:

Menisphermum Dauricum, Pharmacology, Phenolic Alkaloids, Progress

Export:

RIS, BibTeX

Price:

Permissions CCC:

Request Permissions

Permissions PLS:

Request Permissions

Сopyright:

© 2015 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

* - Corresponding Author

References

[1] Feigin VL, Lawes CM, Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century, Lancet Neurol. 2 (2003) 43-53.

DOI: 10.1016/s1474-4422(03)00266-7

Google Scholar

[2] Donnan GA, Fisher M, Davis SM, Stroke, Lancet. 371 (2008) 1612-1623.

Google Scholar

[3] Woitzik J, Back T, Flow-dependent versus spreading-like impairment of brain tissue integrity during focal cerebral ischemia and its consequences for neuroprotective strategies, Front Biosci. 13 (2008)1500-1506.

DOI: 10.2741/2776

Google Scholar

[4] Lambertsen KL, Biber K, Inflammatory cytokines in experimental and human stroke, J Cereb Blood Flow Metab. 32 (2012) 1677-1698.

DOI: 10.1038/jcbfm.2012.88

Google Scholar

[5] Li SN, Zhang KY, Effects of dauricine on Ventricular action potential and low inward ion flow, Acta Pharmacol. 13 (1992) 535-538.

Google Scholar

[6] Guo DL, Zhou ZN, Inhibitory effects of dauricine on L currents in guinea pig ventricular myocytes, Acta Pharmacol. 5 (1997) 9-12.

Google Scholar

[7] Zhou LL, Yan XW, Original study of the effect of dauricine on Mechano-Electric Feedback, Journal of Emergency Resuscitation and Disaster Medicine. 1 (2006) 95-98.

Google Scholar

[8] Xia JS, Guo DL, Zhang Y, Inhibitory effects of dauricine on Potassium currents in guinea pig ventricular myocytes, Acta Pharmacol. 21 (2000) 60-64.

Google Scholar

[9] Xia JS, HU T, Dauricine suppressed Cscl-induced early after depolarizations and triggered arrhythmias in rabbit hearts in vivo, Acta Pharmacol. 6 (1996) 8-10.

Google Scholar

[10] Xia JS, Dauricine suppressed Cscl-induced early after depolarizations and triggered arrhythmias in rabbit hearts in vivo, Acta Pharmacol. 20 (1999) 512.

Google Scholar

[11] Li SQ, Fu Y, 31 cases of clinical observation of the treatment of dauricine on arrhythmia, Chinese Journal of Practical Internal Medicine. 8 (1998) 22-25.

Google Scholar

[12] Guan F, Effect of dauricine on endothelial function of myocardial ischemia reperfusion injury, Traditional Chinese Medicine Research. 16 (2000) 46-47.

Google Scholar

[13] Wang DQ, Zhang YZ, Effect of dauricine on the NE release of ischemic myocardium and reperfusion ventricular fibrillation, Central Plains Medical Journal. 31 (2004) 15-16.

Google Scholar

[14] Su YM, Su H, Sheng B, Protective effect of dauricine on experimental myocardial ischemia hemodynamics, China Pharmacist. 7 (2004) 83-85.

Google Scholar

[15] Pei LY, Li YQ, Protective effect of dauricine on myocardial ischemia and ischemia reperfusion injury, The Chinese Journal of Clinical. 28 (2012) 518-521.

Google Scholar

[16] Li YQ, Gong PL, Protective effect of dauricine on myocardial stunning of rats in vitro, Acta Pharmaceutica Sinica. 36 (2001) 894-897.

Google Scholar

[17] Guan F, Cheng B, Effect of dauricine on endothelial function of rabbit ischemia reperfusion injury, Journal of Clinical Cardiology. 17 (2001) 407-408.

Google Scholar

[18] Li YM, Li RH, Protective effect of dauricine on experimental myocardial ischemia Journal of Chinese PLA Postgraduate Medical School. 3 (1993) 19.

Google Scholar

[19] Xiao JY, Su YM, Effect of dauricine on the Bcl-2 and Bax expression of ischemic brain injury, Journal of Harbin University of Commerce. 24 (2008) 16-19.

Google Scholar

[20] He Z, Sun T, Effect of dauricine on potential in hippocampus CA3 of cerebral ischemia in rats, Journal of Huazhong University of Science and Technology. 34 (2005) 266-269.

Google Scholar

[21] Yang RQ, Su YM, Liu X, Protective effect of dauricine on experimental cerebral ischemia, Chinese Journal of Information on Traditional Chinese Medicine. 19 (2002) 61-62.

Google Scholar

[22] Han H, Yu XJ, Effect of dauricine on whole blood viscosity and cerebral blood flow in rats, Acta Chinese Medicine and Pharmacology. 35 (2007) 12-13.

Google Scholar

[23] Wang M, Liu GQ,  Daurisoline decreased the neurotoxicity by inhibited the intracellular free calcium induced by NMDA, Chinese Pharmaceutical Journal. 34 (1999) 739.

Google Scholar

[24] XJ Zhang, B Wan, Effect of dauricine on encephaledema of ischemia reperfusion in rats and the permeability of blood brain barrier, Pharmacy Today. 20 (2010) 11-13.

Google Scholar

[25] Q LV, Ling Q, Effect of dauricine on the Bcl-2 and Bax expresstion of ischemic brain injury inrats, Chinese Traditional and Herbal Drugs. 35 (2004) 185-187.

Google Scholar

[26] Xiao J, LJ Guo, Protective effect of dauricine on Secondary inflammatory damage of local brain cerebral ischemia reperfusion, Acta Pharmaceutica Sinica. 39 (2004) 661-665.

Google Scholar

[27] J Xiao, YF Luo, Protective effect of dauricine on local brain cerebral ischemia reperfusion injury, Chinese Traditional and Herbal Drugs. 37 (2007) 1367-1369.

Google Scholar

[28] F Wang, G Zhao, Protective effect of dauricine on brain cerebral ischemia reperfusion injury in rabbits, Chinese emergency medicine of critical disease. 17 (2005) 154-156.

Google Scholar

[29] QH Duan, ZQ Wang, Effect of dauricine against cerebral ischemia reperfusion injury of Neuron, Journal of Huazhong University of Science and Technology. 37 (2008) 141-144.

Google Scholar

[30] YQ Du, Y Bai, Effect of dauricine on the PKB expression of cerebral ischemia rats, Journal of Jiangsu University (Medicine Edition). 18 (2008) 383-385.

Google Scholar

[31] DZ Zhao, YQ Du, Effect of dauricine on the c-fos expression of cerebral ischemia rats, China Pharmacist. 12 (2009) 1005-1008.

Google Scholar

[32] YH Li, PL Gong, Protective effect of dauricine on cerebral ischemia in rats, Chinese Pharmacological Bulletin. 20 (2004) 564-567.

Google Scholar

[33] XY Yang, B Zhou, Therapeutic action of dauricine on local cerebral ischemia reperfusion injury in rats, Chinese Pharmacological Bulletin. 21 (2005) 1112-1115.

Google Scholar

[34] XY Kong, PL Gong, Effect of dauricine on thrombogenesis and platelet aggregation, Acta Pharmaceutica Sinica. 40 (2005) 916-919.

Google Scholar

[35] T Guo, YZ Zhang, Dauricine inhibited the distribution of platelet membrane glycoprotein induced by thrombin and the release of thrombin-sensitive proteins, Acta Pharmacologica Sinica. 6 (1999) 13-15.

Google Scholar

[36] YZ Zhang, JX Zhu, Effect of dauricine on platelet aggregation of acute myocardial infarction patients, Chinese Pharmacological Bulletin. 18 (2002) 97-98.

Google Scholar

[37] D Ke, Y Ren, Dauricine inhibited the increase of intracellular calcium induced by  bradykinin, Journal of Huazhong University of Science and Technology. 33 (2004) 669-671.

Google Scholar

[38] YM Su, C Zhang, Effect of dauricine on the proliferation of human tumor cells PC-3 and BT5637, Journal of Harbin Medical University. 41(2007) 129-131.

Google Scholar

[39] BE Shan, WJ Liang, The research of chinese pharmacy herbal asiatic moonseed rhizome on anti-tumor in vitro, Chinese Pharmacological Bulletin. 16 (2004) 293-295.

Google Scholar

[40] M Li, WJ Liang, Inhibitory effect of dauricine on the proliferation of human bladder cancer T224 cells, Journal of Third Military Medical University. 28 (2006) 1860-1863.

Google Scholar

[41] X L, XW Liu, Anti-tumor effect of dauricine on gastric cancer mice, Heilongjiang Medicine and Pharmacy. 35 (2012) 78-79.

Google Scholar

[42] YM Su, JY Xiao, Effect of dauricine on the proliferation of cancer  cells K562 and BXPC-3, Journal of Harbin Medical University. 41(2007) 129-131.

Google Scholar

[43] YM Su, FX Meng, Effect of dauricine on the proliferation of cancer  cells K562 and BXPC-3, Journal of Gansu College of TCM. 25 (2008) 1-4.

Google Scholar

[44] ZY He, XH Liu, The research of dauricine on reversal effects of drug resistance, Journal of Jiangsu University (Medicine Edition). 20 (2010) 108-112.

Google Scholar

[45] BE Shan, WJ Liang, Experimental study of PE2 extracted from rhizoma menispermi on inducing cancer cell apoptosis, Carcinogenesis, Teratogenesis and Mutagenesis. 18 (2006) 269-272.

Google Scholar

[46] BE Shan, DQ LiU, Experimental study of PE2 extracted from rhizoma menispermi on anti-tumor effect in vivo and the immunoregulatory mechanism, Carcinogenesis, Teratogenesis and Mutagenesis. 18 (2006) 351-354.

Google Scholar

[47] YM Su, YH Li, Effect of dauricine on the content of MMP-2 in tumor issue of BXPC-3, Journal of Chengdu medical college. 5 (2010) 113-115.

Google Scholar

[48] XY Wen, GY Jiao, Effect of dauricine on the content of iNOS in cancer  cells BXPC-3, China Pharmacy. 20 (2009) 1370-1372.

Google Scholar

[49] D Meng, Y Bai, Effect of dauricine on the content of TNF-α in cancer  cells BXPC-3, China Pharmacy. 20 (2009) 1370-1372.

Google Scholar

[50] YM Su, WJ Li, Effect of dauricine on the expression of VEGF and FG, China Pharmacy. 5 (2010) 245-247.

Google Scholar

[51] YM Su, Y Zhang, Effect of dauricine on the expression of p.16, Acta Chinese Medicine and Pharmacology. 38 (2010) 35-37.

Google Scholar

[52] ZG Zhou, Y Bai, Effect of dauricine on the expression of p.53, Acta Chinese Medicine and Pharmacology. 39 (2011) 31-33.

Google Scholar

[53] DZ Feng, Y Bai, Effect of dauricine on the expression of K-ras, Information on Traditional Chinese Medicine. 27 (2010) 112-114.

Google Scholar

[54] DZ Feng, Y Bai, Effect of dauricine on the expression of DPC4 and DPC4 mRNA in pancreatic cancer tissue. 27 (2010) 23-25.

Google Scholar

[55] JH Li, FQ Qin, The research of dauricine on multidrug resistance, Journal of Dalian Medical University. 23 (2002) 94-96.

Google Scholar

[56] FQ Su, LP, Wang, Effect of dauricine on the ability of learning and memory, China Pharmaceuticals, 10 (2003) 16-17.

Google Scholar

[57] CL Liu, ZF Dian, Experimental research on antioxidant and lipid lowering, Chinese Journal of Clinical Pharmacology. 10 (2005) 343-347.

Google Scholar

© 2025 Trans Tech Publications Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For open access content, terms of the Creative Commons licensing CC-BY are applied.
Scientific.Net is a registered trademark of Trans Tech Publications Ltd.